First-line brentuximab vedotin plus chemotherapy to improve overall survival in patients with stage III/IV classical Hodgkin lymphoma: An updated analysis of ECHELON-1 Meeting Abstract
| Authors: | Ansell, S. M.; Connors, J. M.; Radford, J. A.; Kim, W. S.; Gallamini, A.; Ramchandren, R.; Friedberg, J. W.; Advani, R. H.; Hutchings, M.; Evens, A. M.; Smolewski, P.; Savage, K. J.; Bartlett, N. L.; Eom, H. S.; Abramson, J. S.; Dong, C.; Campana, F.; Fenton, K.; Puhlmann, M.; Straus, D. J. |
| Abstract Title: | First-line brentuximab vedotin plus chemotherapy to improve overall survival in patients with stage III/IV classical Hodgkin lymphoma: An updated analysis of ECHELON-1 |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301966 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.7503 |
| Notes: | Meeting Abstract: 7503 -- This meeting was also held virtually -- Source: Wos |
